Full Text View
Tabular View
No Study Results Posted
Related Studies
Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia
This study is currently recruiting participants.
Verified January 2012 by Apceth GmbH & Co. KG
Study NCT01351610   Information provided by Apceth GmbH & Co. KG

First Received on May 10, 2011.   Last Updated on January 30, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Critical Limb Ischemia
Peripheral Artery Disease
Additional conditions recognized in this trial
Arterial Occlusive Diseases
Ischemia
Peripheral Arterial Disease
More general conditions related to this trial
Arteriosclerosis
Atherosclerosis
Cardiovascular Diseases
Pathologic Processes
Peripheral Vascular Diseases
Vascular Diseases
Interventions listed in this trial
PTA + Infusion of MSC_Apceth
PTA
Sponsors listed in this trial
Apceth GmbH & Co. KG


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services